Marco van de Weert

Marco van de Weert

Associate Professor


  1. 2019
  2. Published

    The dangers of citing papers you did not read or understand

    van de Weert, Marco & Stella, L., 15 Jun 2019, In: Journal of Molecular Structure: THEOCHEM. 1186, p. 102-103 2 p.

    Research output: Contribution to journalJournal article

  3. 2013
  4. Published

    Characterization of Therapeutic Peptides and Proteins

    van de Weert, Marco & Arvinte, T., 2013, Pharmaceutical Formulation Development of Peptides and Proteins. Hovgaard, L., Frokjaer, S. & van de Weert, M. (eds.). 2 ed. Boca Raton: CRC Press, p. 49-78

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  5. Published

    Physical Instability of Peptides and Proteins

    van de Weert, Marco & Randolph, T. W., 2013, Pharmaceutical Formulation Development of Peptides and Proteins. Hovgaard, L., Frokjaer, S. & van de Weert, M. (eds.). 2 ed. Boca Raton: CRC Press, p. 107-130

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  6. 2009
  7. Published

    Delivery technologies for biopharmaceuticals: a critical assessment

    van de Weert, Marco, 2009, Delivery technologies for biopharmaceuticals: Peptides, proteins, nucleic acids and vaccines. Jørgensen, L. & Mørck Nielsen, H. (eds.). Chichester: Wiley, p. 407-411

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  8. Published

    Infrared spectroscopy of protein pharmaceuticals

    van de Weert, Marco & Jørgensen, Lene, 2009, Advances in Biomedical Spectroscopy: Biological and Biomedical Infrared Spectrocopy. Barth, A. & Haris, P. I. (eds.). Amsterdam: IOS Press, Vol. 2. p. 168-177

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  9. 2008
  10. Published

    Immunogenicity of biopharmaceuticals: methods to reduce immunogenicity and biosimilars

    van de Weert, Marco & Møller, E. H., 2008, Immunogenicity of biopharmaceuticals. van de Weert, M. & Møller, E. H. (eds.). 1 ed. New York: Springer, p. 97-111

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  11. 2007
  12. Published

    Gennembrud i forståelsen af insulinfibrillering

    Jensen, M. G., Vestergaard, Bente, Frøkjær, Sven, Gajhede, Michael, Flink, J. M., van de Weert, Marco, Kastrup, Jette Sandholm Jensen & Svergun, D. I., 2007, In: Lægemiddelforskning. p. 10-11

    Research output: Contribution to journalJournal article

  13. 2005
  14. Published

    Fourier transform infrared spectroscopy of protein formulations

    van de Weert, Marco, Hering, J. A. & Haris, P. I., 2005, Methods for Structural Analysis of Protein Pharmaceuticals. Jiskoot, W. & Crommelin, D. (eds.). Arlington: Springer Science+Business Media, p. 131-166

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  15. 2004
  16. Published

    Formulation, stability and characterization of protein and peptide drugs

    Frøkjær, Sven, Hovgaard, L. & van de Weert, Marco, 2004, Biomaterials for Delivery and Targeting of Proteins and Nucleic Acids. Mahato, R. I. (ed.). Boca Raton: CRC Press, p. 378-401

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

  17. 1998
  18. Stability of pharmaceutical proteins in particulate carriers

    van de Weert, Marco, van 't Hof, R., Hennink, W. E. & Crommelin, D. J. A., 1998, Alfred Benzon Symposium proceedings. Frøkjær, S., Christrup, L. & Krogsgaard-Larsen, P. (eds.). Copenhagen: Munksgaard , Vol. 43. p. 359-375

    Research output: Chapter in Book/Report/Conference proceedingBook chapterCommunication

ID: 1302800